Phase 2 Discovery, Inc. Company Profile

16:38 EDT 17th March 2018 | BioPortfolio

Phase 2 Discovery (P2D) is a pharmaceutical company focused on developing innovative drugs that fulfill unmet medical needs in the treatment of central nervous system (CNS) disorders such as insomnia, anxiety, depression, attention disorders and neurodegenerative diseases including amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS).
At P2D, we are using our understanding of the treatment of CNS disorders and neurodegenerative diseases and our experienced team to efficiently build a product portfolio of therapeutics with a greater likelihood for clinical success. Our goal is to advance a product candidate through clinical proof of concept by producing powerful and compelling clinical data and then seeking partners to complete development and commercialization.


3130 Highland Ave
United States of America


Phone: (513) 475-6618
Fax: (513) 221-1891

News Articles [1138 Associated News Articles listed on BioPortfolio]

VIDEO: Dimerix CEO On Surprising Phase II Data Discovery

Dimerix is changing its R&D strategy for kidney disease drug based on surprising findings from a Phase II study.   

Mustang Bio Announces $12.8M Grant to Fund Phase I Trial of CAR-T Therapy in Malignant Glioma

NewsThe funds will be used to support two expanded arms of the Phase I trial.

Irori, Afferent Link Solid Phase Synthesis Products with Combinational Chemistry Software

Irori (La Jolla, CA), a subsidiary of Discovery Partners International and a provider of drug discovery technologies, has signed a collaboration agreement with Afferent Systems Inc. (San Francisco), a...

PharmaMar Endures Second Recent Setback With Phase III Ovarian Cancer Failure

Zepsyre did not show a PFS advantage measured against a comparator regimen in platinum-resistant ovarian cancer, but the novel chemotherapy...   

Blue Oak and PsychoGenics partner on drug discovery

Blue Oak Pharmaceuticals and PGI Drug Discovery have entered into a partnership to discover and optimize novel treatments for brain disorders and psychiatric conditions. Under the terms of the agreeme...

Pipeline Watch: Phase III Readouts For Talazoparib, Ampion, Avatrombopag

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical...   

Cancer Research UK announces drug discovery collaboration with Celgene Corporation

Press release (Friday) - Cancer Research UK today announced the signing of a five-year drug-discovery collaboration between its subsidiary, Cancer Research Technology (CRT), and Celgene Corporation...

Hybrigenics (ALHYG) - Inecalcitol advancing towards data

Edison Investment Research - Pharmaceutical & healthcare - Hybrigenics: Hybrigenics’ main value driver is inecalcitol. A Phase II study in chronic myeloid leukaemia (CML) is on track to complete...

Drugs and Medications [21 Associated Drugs and Medications listed on BioPortfolio]

Caraderma [A Refreshing Discovery, Inc.]

CaraDerma acne treatment

Granisetron hydrochloride [Breckenridge Pharmaceutical, Inc.]


Sprycel [E.R. Squibb & Sons, L.L.C.]

These highlights do not include all the information needed to use SPRYCEL safely and effectively. See full prescribing information for SPRYCEL. SPRYCEL (dasatinib) Tablet for Oral Use Initial U.S. App...

Temodar [Schering Corporation]

These highlights do not include all the information needed to use TEMODAR safely and effectively. See full prescribing information for TEMODAR. TEMODAR (temozolomide) CapsulesTEMODAR (temozolomide) fo...

Temodar [Physicians Total Care, Inc.]

These highlights do not include all the information needed to use TEMODAR safely and effectively. See full prescribing information for TEMODAR. TEMODAR (temozolomide) CapsulesTEMODAR (temozolomide) fo...

PubMed Articles [1989 Associated PubMed Articles listed on BioPortfolio]

The Preclinical Discovery and Development Of Brivaracetam For The Treatment Of Focal Epilepsy.

Brivaracetam (BRV) is a new AED currently licensed for the adjunctive treatment of adult patients with focal epilepsies. It is a ligand of the ubiquitous synaptic vesicle glycoprotein 2A (SV2A). Areas...

Improving the discovery of secondary metabolite natural products using ion mobility-mass spectrometry.

Secondary metabolite discovery requires an unbiased, comprehensive workflow to detect unknown unknowns for which little to no molecular knowledge exists. Untargeted mass spectrometry-based metabolomic...

Discovery of Rogaratinib (BAY 1163877): a pan-FGFR Inhibitor.

Rogaratinib (BAY 1163877) is a highly potent and selective small-molecule pan-fibroblast growth factor receptor (FGFR) inhibitor (FGFR1-4) for oral application currently being investigated in phase ...

Lorlatinib in ALK+ NSCLC: Robust Phase II Efficacy Seen.

The investigational ALK inhibitor lorlatinib, whose early clinical activity was first reported last year, continues to look promising in advanced ALK-positive or ROS1-positive non-small cell lung canc...

Crizotinib Has Antitumor Activity in ALK-Positive ALCL and IMT.

Crizotinib has an overall response rate of 90% in ALCL and 86% in IMT at the recommended phase II dose.

Clinical Trials [1226 Associated Clinical Trials listed on BioPortfolio]

Discovery Elbow Multi-Center Prospective Study

The purpose of this prospective clinical trial is to document the performance and clinical outcomes of Biomet Discovery Elbow.

Protein Biomarker Discovery and Validation in Chronic Obstructive Pulmonary Disease (COPD) And Asthma

The purpose of the study is to better understand the function of asthma and COPD, and response to therapy. There are two Phases to this study broken into two arms. In Phase I, our propose ...

A Clinical Investigation of the Discovery™ Elbow System

The purpose of this study is to perform a five-year, multi-center prospective evaluation of the Discovery™ Elbow System for outcome and durability. Relief of pain and restoration of fun...

Endometriosis Biomarker Discovery Study

This is a prospective, Single time point, discovery study intending to identify biomarkers that can differentiate endometriosis from other underlying reasons for pelvic pain. Patients unde...

Biologic Basis of Liver Cancer From Chronic Hepatitis B

The focus of the study is to identify viral factors and host immune responses that differentiate HBV-related HCC patients from HBV patients who have not progressed to HCC. To that end, the...

Companies [1841 Associated Companies listed on BioPortfolio]

ACADIA Pharmaceuticals Inc.

ACADIA is a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders. ACA...

Newron Pharmaceuticals SpA

Newron Pharmaceuticals SpA is a clinical stage biopharmaceutical company focused on the discovery and development of small molecule drugs for the treatment of central nervous system (CNS) diseases. Ou...

DOV Pharmaceutical

We are a biopharmaceutical company focused on the discovery, acquisition, development and commercialization of novel drug candidates for central nervous system, cardiovascular and urological disorders...

Euthymics Bioscience, Inc.

DOV is a biopharmaceutical company historically focused on the development of novel product candidates for disorders of the central nervous system. DOV has previously funded drug development and disco...

Scios Incorporated

Scios Inc. is a biopharmaceutical company engaged in the discovery, development, manufacture and commercialization of novel human therapeutics based upon its capabilities in both protein-...

More Information about "Phase 2 Discovery, Inc." on BioPortfolio

We have published hundreds of Phase 2 Discovery, Inc. news stories on BioPortfolio along with dozens of Phase 2 Discovery, Inc. Clinical Trials and PubMed Articles about Phase 2 Discovery, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Phase 2 Discovery, Inc. Companies in our database. You can also find out about relevant Phase 2 Discovery, Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Sleep Disorders
Sleep disorders disrupt sleep during the night, or cause sleepiness during the day, caused by physiological or psychological factors. The common ones include snoring and sleep apnea, insomnia, parasomnias, sleep paralysis, restless legs syndrome, circa...

Corporate Database Quicklinks

Searches Linking to this Company Record